assessment of AMD risk
AMD prevention
personalised risk assessment of AMD
dry AMD
non-genetic risk factors
biochemical risk factors
progression of advanced AMD
highrisk subgroups of AMD patients
Determination of AMD frequency
non-genetic factors
integration of risk profiles
molecular genetics
molecular level
pathways Age-related macular degeneration
assessment of lifestyle
personalised risks
therapy development
combined role of genetic
identification of molecular drivers
systems level analysis of disease subgroups
stratification of disease risks
web-based prediction model
biochemical testing
WP5
WP4
New insights
WP6
medical management of high-risk subgroups of patients
functional characterisation of pathophysiological pathways
integrated analysis of current knowledge
interpretation of pathophysiological consequences of risks
biological pathways relevant
in-depth retinal imaging
development of robust algorithms
clinical phenotype
epidemiological data
clinical guidelines
gained knowledge
current proposal
important age-related blinding disorder
long-lasting prevention
major insights
Experimental testing
identification of novel biomarkers
preventive medical recommendations
new therapeutic targets
existing longitudinal European epidemiological cohorts
biobanks
onset
worldâ€™s
nutrition
Modelling
refinement
dissemination
work
Promotion
extension
interaction
Key deliverables
WP1
WP7